Core Viewpoint - InnoCare (02577) shares surged over 13%, reaching a new high of HKD 98.7, following the release of its interim performance report, which showed significant growth in sales and improvements in profitability metrics [1] Financial Performance - The company reported a sales revenue of HKD 553 million for the first half of the year, representing a year-on-year increase of 43.4% [1] - The gross margin improved to 6.8%, marking a substantial increase of 28.4 percentage points compared to the same period in 2024, achieving positive gross profit for the first time [1] - The net loss narrowed to approximately HKD 429 million, a reduction of 12.16% year-on-year [1] Market Developments - Sales related to AI and data centers experienced a remarkable year-on-year growth of 180% [1] - The company has entered mass production for its 100V gallium nitride (GaN) applications in the 48V-12V range [1] Product Innovations - InnoCare has collaborated with leading companies in the robotics sector to launch the world's first gallium nitride robot [1] - The company anticipates that the shipment of gallium nitride chips for robots will exceed 10,000 units this year, with each robot requiring approximately 300 gallium nitride chips [1] - As technology continues to evolve, the demand for gallium nitride chips in humanoid robots is expected to rise significantly, with the usage per robot projected to increase to 1,000 chips for more complex movements [1]
港股异动 | 英诺赛科(02577)飙升逾13%再创新高 上半年实现毛利转正 AI及数据中心销售同比增长180%